U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692230) titled 'MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer' on June 26.
Brief Summary: Luminal breast cancer is characterized by marked heterogeneity, resulting in diverse treatment responses and long-term outcomes. This project aims to integrate MRI and multiomics data to achieve non-invasive molecular typing and precise response prediction. By linking imaging phenotypes with underlying molecular and pathological characteristics, the investigators will develop predictive models for treatment resistance, recurrence, and metastasis, ultimately supporting personalized treatment strategies and precision oncology.
Stu...